Publicaciones en colaboración con investigadoras/es de Centro Nacional de Microbiología (83)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Discovering Mathematical Patterns Behind HIV-1 Genetic Recombination: A New Methodology to Identify Viral Features

    IEEE Access, Vol. 11, pp. 95796-95812

  3. Executive summary of the consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), Spanish Society of Neurology (SEN), Spanish Society of Immunology (SEI), Spanish Society of Pediatric Infectology (SEIP), Spanish Society of Rheumatology (SER), and Spanish Academy of Dermatology and Venereology (AEDV), on the diagnosis, treatment and prevention of Lyme borreliosis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 1, pp. 40-45

2022

  1. Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study

    Medicine (United States), Vol. 101, Núm. 24, pp. E29252

  2. Long-Term Changes of Inflammatory Biomarkers in Individuals on Suppressive Three-Drug or Two-Drug Antiretroviral Regimens

    Frontiers in Immunology, Vol. 13

  3. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Author Correction: Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America (Scientific Reports, (2021), 11, 1, (11442), 10.1038/s41598-021-90023-x)

    Scientific Reports

  2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  3. Do high MICs predict the outcome in invasive fusariosis?

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 4, pp. 1063-1069

  4. HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients

    Journal of Biomedical Science, Vol. 28, Núm. 1

  5. Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America

    Scientific Reports, Vol. 11, Núm. 1

  6. Identification of a New HIV-1 BC Intersubtype Circulating Recombinant Form (CRF108_BC) in Spain

    Viruses, Vol. 13, Núm. 1

  7. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

  8. Low sensitivity of conventional fungal agars in fungemia by Rhodotorula mucilaginosa: description of two cases

    Annals of Clinical Microbiology and Antimicrobials, Vol. 20, Núm. 1

  9. Multicenter evaluation of the Panbio™ COVID-19 rapid antigen-detection test for the diagnosis of SARS-CoV-2 infection

    Clinical Microbiology and Infection, Vol. 27, Núm. 5, pp. 758-761

  10. Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort

    Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1678-1684

2020

  1. Brief Report: CYP27B1 rs10877012 T Allele Was Linked to Non-AIDS Progression in ART-Naïve HIV-Infected Patients: A Retrospective Study

    Journal of acquired immune deficiency syndromes (1999), Vol. 85, Núm. 5, pp. 659-664

  2. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients

    Frontiers in Immunology, Vol. 11

  3. Fungal co-infection in COVID-19 patients: Should we be concerned?

    Revista Iberoamericana de Micologia

  4. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8